Acylated ghrelin and leptin concentrations in patients with type 2 diabetes mellitus, people with prediabetes and first degree relatives of patients with diabetes, a comparative study
Tóm tắt
Ghrelin is known as a new endocrine component supposed to have an influence in control of feeding behavior and energy balance. Recent studies have shown that ghrelin concentration in the subjects with diabetes mellitus type 2 (DM 2) is lower than normal. To clarify the relationship between ghrelin and insulin resistance and also DM 2, a cross-sectional study was designed. In a cross-sectional study, 87 subjects were enrolled in three groups, 29 with DM2, 29 pre-diabetes state and 29 normoglycemic subjects of first-degree relatives of diabetic group. After clinical examination, blood samples were taken to measure fasting blood glucose, HbA1c, lipids, insulin, leptin and acylated ghrelin concentrations. Mean serum concentrations of acylated ghrelin in all groups (47.4 ± 27.9 pg/ml) were lower than normal values (150.3 ± 56.4 pg/ml) (P: 0.006) without significant difference within groups comparison(P: 0.1). A significant correlation was found between ghrelin concentration with body mass index (BMI) (r: -0.23, p <0.02) and abdominal circumference (AC) (r: -0.28, P < 0.008). Also inverse relationship between ghrelin level and insulin resistance (HOMA-IR) (r: -.032, p: 0.002) was seen in all subjects. Leptin level has a significant correlation with abdominal circumference (AC) and BMI (P < 0.0001) but not with ghrelin. This study showed that obesity has a strong association with the reduced level of ghrelin concentration. It seems that the process of ghrelin reduction is initiated in earlier stages of insulin resistance prior to the onset of overt DM.
Tài liệu tham khảo
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2009,32(l):S62-S67.
Lin Y, Sun Z: Current views on type 2 diabetes. J Endocrinol 2010,204(1):1–11. 10.1677/JOE-09-0260
Edmann J, Lipple F, Wagenpfeil S, et al.: Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 2005, 55: 8–1371.
Garcia E, King P, Ohgusu H, et al.: The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol 2009, 161: 307–315. 10.1530/EJE-09-0122
Hasuda H, Kojima M, Kangawa K: Biological, physiological aspects of ghrelin. J pharmacol Sci 2006, 100: 398–410. 10.1254/jphs.CRJ06002X
Ukkola O: Ghrelin in Type 2 diabetes mellitus and metabolic syndrome. Mol Cell Endocrinol 2011,340(1):8–26.
Delhanty PJ, Neggers SJ, van der Lely AJ: Mechanisms in endocrinology: Ghrelin: the differences between acyl- and des-acyl. Eur J Endocrinol 2012,167(5):8–601.
Dezaki K, Sone H, Yada T: Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. pharmacol therapeutics 2008, 118: 239–249. 10.1016/j.pharmthera.2008.02.008
Al Massadi O, Tschöp MH, Tong J: Ghrelin acylation and metabolic control. Peptides 2011,32(11):8–2301.
Delhanty PJ, van der Lely AJ: Ghrelin and glucose homeostasis. Peptides 2011,32(11):18–2309.
Verhulst PJ, Depoortere I: Ghrelin's second life: from appetite stimulator to glucose regulator. World J Gastroenterol 2012,18(25):95–3183.
Gelling R, Overduin J, Morrison C, et al.: Effect of uncontrolled diabetes on plasma ghrelin concentrations and ghrelin-induced feeding. Endocrinology 2004, 145: 82–4575.
Seppo M, Kellokoski M, Horkko S, et al.: Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 Diabetes. Diabetes 2003, 52: 52–2546.
Matthews DR, Hosker JP, Rudenski AS, et al.: Homeostasis model assessment: insulin resistance and beta-cell function fromfasting plasma glucose and insulin concentrationsin man. Diabetologia 1985, 28: 412–419. 10.1007/BF00280883
Monti V, Carlson JJ, Hunt SC, et al.: Relationship of ghrelin and leptin hormones with body mass index and waist circumference in a random sample of adults. J Am Diet Assoc 2006,106(6):8–822.
Coll AP, Farooqi IS, O’Rahilly S: The hormonal control of food intake. Cell 2007, 129: 251–262. 10.1016/j.cell.2007.04.001
Stanley S, Wynne K, McGowan B, et al.: Hormonal regulation of food intake. Physiol Rev 2005, 85: 1131–1158. 10.1152/physrev.00015.2004
Hayashida T, Nakahara K, Mondal MS: Date et al. Ghrelin in neonatal rats: distribution in stomach and its possible role. J Endocrinol 2002, 173: 239–245. 10.1677/joe.0.1730239
Hosoda H, Kojima M, Matsuo H, et al.: Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000, 279: 909–913. 10.1006/bbrc.2000.4039
Poyoko S, Ukkola O, Kauma H, et al.: The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes. Diabetologia 2005, 10: 9–1635.